imc indymedia

Los Angeles Indymedia : Activist News

white themeblack themered themetheme help
About Us Contact Us Calendar Publish RSS
latest news
best of news




A-Infos Radio

Indymedia On Air

Dope-X-Resistance-LA List


IMC Network:

Original Cities africa: ambazonia canarias estrecho / madiaq kenya nigeria south africa canada: hamilton london, ontario maritimes montreal ontario ottawa quebec thunder bay vancouver victoria windsor winnipeg east asia: burma jakarta japan korea manila qc europe: abruzzo alacant andorra antwerpen armenia athens austria barcelona belarus belgium belgrade bristol brussels bulgaria calabria croatia cyprus emilia-romagna estrecho / madiaq euskal herria galiza germany grenoble hungary ireland istanbul italy la plana liege liguria lille linksunten lombardia london madrid malta marseille nantes napoli netherlands nice northern england norway oost-vlaanderen paris/Île-de-france patras piemonte poland portugal roma romania russia saint-petersburg scotland sverige switzerland thessaloniki torun toscana toulouse ukraine united kingdom valencia latin america: argentina bolivia chiapas chile chile sur cmi brasil colombia ecuador mexico peru puerto rico qollasuyu rosario santiago tijuana uruguay valparaiso venezuela venezuela oceania: adelaide aotearoa brisbane burma darwin jakarta manila melbourne perth qc sydney south asia: india mumbai united states: arizona arkansas asheville atlanta austin baltimore big muddy binghamton boston buffalo charlottesville chicago cleveland colorado columbus dc hawaii houston hudson mohawk kansas city la madison maine miami michigan milwaukee minneapolis/st. paul new hampshire new jersey new mexico new orleans north carolina north texas nyc oklahoma philadelphia pittsburgh portland richmond rochester rogue valley saint louis san diego san francisco san francisco bay area santa barbara santa cruz, ca sarasota seattle tampa bay tennessee urbana-champaign vermont western mass worcester west asia: armenia beirut israel palestine process: fbi/legal updates mailing lists process & imc docs tech volunteer projects: print radio satellite tv video regions: oceania united states topics: biotech

Surviving Cities africa: canada: quebec east asia: japan europe: athens barcelona belgium bristol brussels cyprus germany grenoble ireland istanbul lille linksunten nantes netherlands norway portugal united kingdom latin america: argentina cmi brasil rosario oceania: aotearoa united states: austin big muddy binghamton boston chicago columbus la michigan nyc portland rochester saint louis san diego san francisco bay area santa cruz, ca tennessee urbana-champaign worcester west asia: palestine process: fbi/legal updates process & imc docs projects: radio satellite tv
printable version - js reader version - view hidden posts - tags and related articles

Silence = Wealth:

by Starfighter Thursday, Jul. 17, 2003 at 8:06 PM

Deforming Miracles Four years later, after record-breaking approval by the Food and Drug Administration and in the absence of any long-term survival data, it has become clear that protease inhibitors are anything but “miraculous” or “safe.”

Silence = Wealth:

The Greed Behind Project Deform

By David Pasquarelli

Artwork by Graphic Violence

Activist street poster critical of Martin Delaney's drug company financed promotion of protease inhibitors.


They say those who fail to learn from history are doomed to repeat it. Nowhere is this more evident than in the world of AIDS drug promotion where, unable to comprehend the lessons of the 1980’s AZT poisoning fiasco, the gay community is now facing a new round of death and deformity due to rapidly-approved, outrageously-priced and widely-advertised protease inhibitor treatments. One organization, Project Inform, and one man in particular, Martin Delaney, its Founding Director, are largely responsible for this current desperate situation.

Back in 1996, I and other members of ACT UP San Francisco disrupted a forum on new drug guidelines at the International AIDS Conference to force media attention to our well-researched conclusion that protease inhibitors would cause untold suffering and death. Martin Delaney, however, presented his far more optimistic opinions in a mass-mailed fundraising letter for Project Inform:

“By now you probably know the good news: after negotiations with government regulators, we’ve finally won quick approval for a new generation of therapies for HIV/AIDS infected people. These are some of the most potent and promising drugs ever made available,” Delaney gushed. “We have a potential miracle in our hands and, with your generous help, we can bring it safely home.”

Deforming Miracles

Four years later, after record-breaking approval by the Food and Drug Administration and in the absence of any long-term survival data, it has become clear that protease inhibitors are anything but “miraculous” or “safe.”

The list of devastating effects caused by these experimental chemicals, prescribed for life as soon as possible after an HIV positive diagnosis, continue to grow. Sudden death from liver damage, kidney failure, heart attacks, strokes, and diabetes as well as metabolic abnormalities resulting in grotesque physical deformities like hunchbacks, hardened, distended bellies and stick-like limbs have finally made headlines, albeit too late for many.

It is for these reasons that Delaney has lost the trust of many in the patient community and his organization, now known on the streets as “Project Deform,” is increasingly viewed as a threat to the health and well-being of people with AIDS.

A Question of Ethics

Oddly enough, soon before the protease inhibitor implosion hit the pages of magazines and newspapers across America, Project Inform quietly began circulating a draft document entitled Proposed Guidelines for Ethical Relations Between HIV Community Agencies and Pharmaceutical Companies.

The draft document was startlingly forthright in admitting that “industry of all types has long sought to influence government, the public, and in particular, advocates working in fields related to their products. Taken to an extreme, this effort can stretch the limits of ethical behavior.”

Clearly, both Project Inform and Delaney occupy a critical position in transmitting information to HIV-positive individuals from companies that sell profitable antiviral AIDS drugs.

Project Inform lobbies the government for the rapid approval and release of experimental AIDS drugs. Through its toll-free hotline, Project Inform volunteers recommend treatments and encourage frightened HIV-positive individuals to enroll in clinical trials of new drugs. Through its website, publications and local and national treatment forums, Project Inform promotes the latest AIDS drugs to a global audience. The HIV-negative Delaney even sits on AIDS research advisory panels to the National Institutes of Health and National Academy of Sciences - despite having no formal medical training.

Today, it is no secret that Project Inform receives considerable financial support from pharmaceutical companies. In 1998, Project Inform accepted nearly 0,000 from pharmaceutical companies out of .9 million in total raised revenues. Indeed, both Glaxo and Merck each made corporate contributions of 0,000 or more to the organization. Accusations that Project Inform has been corrupted by drug money have lingered for years in San Francisco. In 1995, I outlined how Project Inform’s mission had been severely compromised by the acceptance of pharmaceutical dollars in my essay Exposing Project Infirm (available at

With the protease dream transformed into a nightmare and the sudden emergence of Project Inform’s “ethical guidelines,” it appears that corruption of AIDS agencies may go far deeper than anyone imagined. While the guidelines could be viewed as a proactive measure to come clean before any verifiable improprieties surface, they seem more a skilled attempt to deflect attention away from specific ethical issues.

For example, under “Guiding Principle #1: Disclosure,” Project Inform recommends what has been largely commonplace: that grants over ,000 be announced publicly; that educational materials purchased by drug companies be identified as such; that pharmaceutical and biotech funding be published annually along with the funding’s use; and that agencies develop public statements regarding industry support.

However, suspiciously missing from the document are concrete rules and regulations governing disclosure of personal income obtained from drug companies by executives and staff members of nonprofit AIDS agencies. While it is relatively difficult for highly scrutinized nonprofits to hide a large influx of pharmaceutical dollars, it is quite easy to conceal such payments transacted between private business entities and individuals.

Is it ethical for presidents, executives, board members and staff to secretly amass personal wealth through payments from drug companies or their hired public relations firms in the form of consulting fees, honoraria, in-kind donations and gifts, travel allowances and through stock options?

Of course not. Yet the silence shrouding this area of financial impropriety indicates that it is not only happening but that it is unduly influencing public opinion about the benefits and dangers of experimental AIDS drugs as well as the reasons behind their expensive price. The issue of concealed personal pharmaceutical payoffs becomes most relevant when executives of AIDS non-profits attempt to influence drug costs and public perception in ways that could be legally defined as price-fixing and fraud.

The Sustiva Scandal

For example, when the AIDS drug Sustiva was approved by the Food and Drug Administration in the fall of 1998 its maker, Dupont Pharmaceuticals, faced a carefully orchestrated campaign attacking its efficacy, side effects, and, above all, its price. The campaign was led by Project Inform’s Delaney and Gary Rose of the public relations firm Issuesphere.

The AIDS community assumed that this was just another skirmish in the battle over AIDS drug pricing. However, Delaney’s high-profile PR stunt was very different from previous protests, such as those over the initial ,000 per year price of AZT.

Most importantly, Sustiva, at approximately ,500 per year, was one of the cheapest anti-HIV treatments on the market. There were no protests when Merck priced its new drug Crixivan at about ,000 per year and no screaming when Agouron priced Viracept, a similar protease inhibitor, at ,600 per year then raised the price another 15%. There were no demonstrations over Roche’s Saquinavir priced at ,000, nor over Abbott’s Norvir priced at ,200 nor when Glaxo priced its new nucleoside analogue Ziagen at ,100.

Yet Dupont’s Sustiva met with nationwide demonstrations and outright boycotts. Certainly it was to the advantage of Dupont’s competitors to be free to price their drugs as high as the market would bear without reprisals. It was also to their advantage to see Dupont, a new company just entering the AIDS field, battered in the public eye and forced to reduce its price and profits. A lower price on Sustiva meant more money from the limited funds of the AIDS Drug Assistance Program (ADAP) would be left for the higher priced drugs of Dupont’s competitors. Why pick on Dupont when it had the lowest priced new AIDS drug?

Surprisingly, Delaney claimed that since Sustiva was of a different chemical category from the others its price should be lower. Ordinarily, however, the factors that determine a drug’s price are cost of research, development and manufacture; efficacy and side effects; and market competition. Chemical category is as irrelevant to the price of a drug as color is to the price of a car. More relevant was the financial affiliation of the activist protesters. Delaney and Rose, the two leading individuals who orchestrated the anti-Dupont protests, were paid consultants of Dupont’s competitors or employed by AIDS organizations or public relations firms that received large donations or contracts from Dupont’s competitors. There is something fishy about activists and executives on the payroll of one drug company orchestrating campaigns to influence the drug pricing of a competitor in order to ensure high prices for all AIDS drugs.

Dupont Pharmaceuticals’ protracted fight with Delaney over the pricing of Sustiva took an unexpected turn last spring. Because activists led by Project Inform were hurting its market share in California, Dupont decided to court and lavishly reward the very people who had bashed them six months before. First came a million dollar donation to a dubious San Francisco AIDS prevention panel, a panel that could potentially become an extended job project for Delaney loyalists. Then Dupont sponsored gay pride month at KQED, a local PBS station, and kicked off the event with a dinner honoring Delaney as a hero of the gay community. No less a dignitary than Dupont’s CEO flew in to sing Delaney’s praises.

Given that AIDS drug manufacturers are less competitors and more collaborators in this age of “combination cocktail therapies” it appears that Dupont, the newest member of the AIDS drug cartel, decided it was in their profit-making interests to court rather than offend Delaney.

Public Silence = Personal Wealth

For the last decade Delaney has been rumored to have been a paid consultant for several drug companies including Glaxo Wellcome and Merck, Sharpe and Dohme. When unsuspecting AIDS patients call the Project Inform hotline they believe they are being given objective treatment information from their peers. There is an unethical conflict of interest when pharmaceutical companies pay tax exempt community groups or their leaders to influence AIDS drug pricing or public perceptions about the benefits or dangers of their product or a competitor’s. When patients pay for their drugs they do not expect that quietly compensated AIDS executives have conspired with pharma-ceutical companies to keep drug prices exorbitantly high.

To prevent fraud, price gouging and the victimization of people with AIDS it is imperative that we have full disclosure of all pharmaceutical industry contributions - not only to nonprofit AIDS groups but, more importantly, to all AIDS organizations’ executives, board members and employees.

Therefore, as a public demonstration of their commitment to ethical conduct, I challenge Glaxo Wellcome and Merck, Sharpe and Dohme to publicly disclose all payments and remuneration made over the last ten years to Founding Director Martin Delaney and Project Inform Treatment Information Advocates Brenda Lein and Ben Cheng. I also challenge Delaney, Lein and Cheng to make the same public disclosures by having an independent auditor confirm their IRS tax returns for this time period.

As the sky-high cost of protease inhibitors continues to gobble up more public resources while they injure and kill more patients, it is critical that we pull back the curtain and expose the behind-the-scenes payoffs that fuel the AIDS industry’s engine.

Only by demanding full disclosure from nonprofit AIDS industry executives can we hope to prevent a repeat performance of the AZT/protease inhibitor debacles - taxpayer-funded disasters that will certainly go down as two of the worst examples of medical corruption in American history.

Report this post as:

Local News

Change Links September 2018 posted S02 10:22PM

More Scandals Rock Southern California Nuke Plant San Onofre A30 11:09PM

Site Outage Friday A30 3:49PM

Change Links August 2018 A14 1:56AM

Setback for Developer of SC Farm Land A12 11:09PM

More problems at Shutdown San Onofre Nuke J29 10:40PM

Change Links 2018 July posted J09 8:27PM

More Pix: "Families Belong Together," Pasadena J02 7:16PM

"Families Belong Together" March, Pasadena J02 7:08PM

Short Report on the Families Belong Together Protest in Los Angeles J30 11:26PM

Summer 2018 National Immigrant Solidarity Network News Alert! J11 6:58AM

Watch the Debate: Excluded Candidates for Governor of California M31 5:20AM

Change Links June 2018 posted M28 7:41AM

The Montrose Peace Vigil at 12 Years M22 8:01PM

Unity Archive Project M21 9:42AM

Dianne Feinstein's Promotion of War, Secret Animal Abuse, Military Profiteering, Censorshi M17 10:22PM

CA Senate Bill 1303 would require an independent coroner rather than being part of police M10 9:08PM

Three years after OC snitch scandal, no charges filed against sheriffs deputies M10 8:57PM

California police agencies violate Brown Act (open meetings) M02 8:31PM

Insane Company Wants To Send Nuke Plant Waste To New Mexico A29 11:47PM

Change Links May 2018 A27 8:40AM

Worker-Owned Car Wash on Vermont Closed A27 5:37AM


lausd whistle blower A11 6:58AM

Website Upgrade A10 10:02AM

Help KCET and UCLA identify 60s-70s Chicano images A04 8:02PM

UCLA Luskin: Casting Youth Justice in a Different Light A02 6:58PM

Change Links April 2018 A01 6:27PM

More Local News...

Other/Breaking News

Abolir l'économie S18 11:18AM

The Dictatorship of Corporations S17 5:26PM

18 Lethal Consequences Of Hunting S17 3:13PM

Paraphysique de l'outplacement déontologue S15 6:51AM

Creative Destruction Hack Mod Generator S15 3:49AM

Shopping du bashing S14 8:42AM

After Lehman Brothers, Experts Say Global Financial Crisis Can Happen Again S13 8:28PM

“Animaniacs in Concert!” Starring Voice Legend Rob Paulsen S12 9:30PM

Probabilités de fin d'humanité S12 6:49AM

Florida Area of Migrant Farmworkers Denied Right to Construct Health Clinic near NaplesCIW S11 2:57AM

Propagande de virus, virus de propagande S10 7:34AM

Steer clear of work morality! S09 12:10PM

Sweatshop Lodge Ceremony Continues in US Fed Prisons Led by Inmates S08 6:17PM

Paraphysique de l'origami S08 7:11AM

The Shortwave Report 09/07/18 Listen Globally! S06 11:23PM

August 2018 Honduras Coup update S06 12:28PM

Du réussissement putréfié S06 10:55AM

Brett Kavanaugh Filled The 5th Circuit With Execution Judges S06 6:14AM

Log S06 4:25AM

Augusta Georgia Woman Gets 5 Year Prison Sentence for Writing About Russians Crime Acts S05 8:29AM

Paraphysique de contextualité S05 8:29AM

Crisis Regulation in Global Capitalism S03 3:39PM

Ex-voto de réification S03 10:24AM

Please Oppose Warmonger, Execution and Torture Supporting Bush Operative Brett Kavanaugh A31 10:45PM

Paraphysique d'exploitation occultation A31 10:24PM

Ryan Zinke Is Charging Taxpayers For A Trophy Hunters' Council A31 2:10PM

Is the Financial Crash 2.0 Coming? A31 10:07AM

The Shortwave Report 08/31/18 Listen Globally! A30 11:44PM

More Breaking News...
© 2000-2018 Los Angeles Independent Media Center. Unless otherwise stated by the author, all content is free for non-commercial reuse, reprint, and rebroadcast, on the net and elsewhere. Opinions are those of the contributors and are not necessarily endorsed by the Los Angeles Independent Media Center. Running sf-active v0.9.4 Disclaimer | Privacy